Chelsea G Goodenough
Chelsea G Goodenough is an expert in Oncology at St. Jude Children's Research Hospital (United States). Chelsea G Goodenough has authored 25 publications, the most recent in 2025. SLR score: 84 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Medical Imaging - Sports Medicine - Rheumatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2021 - 2025
Number : 25
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Movement efficiency in survivors of childhood acute lymphoblastic leukemia: a report from the St. Jude lifetime cohort study. PMID 38308806 — precursor cell lymphoblastic leukemia-lymphoma, cohort studies, leukemia, therapeutics, movement | J Cancer Surviv | 2024 | 3 |
| Reliability of In Vivo Creatine-Weighted Chemical Exchange Saturation Transfer (CrCEST) MRI in Calf Skeletal Muscle of Healthy Volunteers at 3 T. PMID 39212126 — exercise, muscles, magnetic resonance imaging, healthy volunteers, muscle, skeletal, creatine | J Magn Reson Imaging | 2024 | 5 |
| Risdiplam for Prenatal Therapy of Spinal Muscular Atrophy. PMID 39970420 — muscular atrophy, atrophy, therapeutics, muscular atrophy, spinal, spine | N Engl J Med Top journal | 2025 | 5 |
| Attributable Risk and Consequences of Bone Mineral Density Deficits in Childhood Cancer Survivors. PMID 39792384 — hypogonadism, cancer survivors, growth, neoplasms, hormones, clinical medicine, prevalence, diagnosis, therapeutics, sedentary behavior, growth hormone, bone density, smoking | JAMA Netw Open | 2025 | 2 |
| Associations between perceived cancer impact and measures of health behavior in survivors of childhood cancer. PMID 39196461 — exercise, cancer survivors, health behavior, pharmaceutical preparations, neoplasms, diet, illicit drugs | J Cancer Surviv | 2024 | 0 |
LeadR Networks
Main global connection map